Kuwait Life Sciences Company
4
32M
3
0.36
1
0.25
1
- Areas of investment
Summary
Kuwait Life Sciences Company is the famous Corporate Investor, which was founded in 2010. The leading representative office of defined Corporate Investor is situated in the Safat. The fund was located in Asia if to be more exact in Kuwait.
The fund was created by Qais Marafie.
Comparing to the other companies, this Kuwait Life Sciences Company performs on 4 percentage points more the average number of lead investments. The high activity for fund was in 2013. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations.
Among the most popular fund investment industries, there are Biotechnology, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Arab Emirates. Among the various public portfolio startups of the fund, we may underline Quanta, SuperSonic Imagine, NewBridge Pharmaceuticals Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Kuwait Life Sciences Company, startups are often financed by NBGI Ventures, Omnes Capital, Bioam Gestion. The meaningful sponsors for the fund in investment in the same round are Wellington Partners, NBGI Ventures, Burrill & Company. In the next rounds fund is usually obtained by btov Partners, Wellington Partners, Seroba Life Sciences.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.36
- Follow on index
- 0.25
- Investments by industry
- Medical Device (4)
- Biotechnology (3)
- Health Care (2)
- Pharmaceutical (2)
- Manufacturing (1) Show 2 more
- Investments by region
-
- United Arab Emirates (2)
- United Kingdom (1)
- France (1)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NewBridge Pharmaceuticals | 20 Sep 2010 | Biotechnology, Medical Device, Pharmaceutical | Early Stage Venture | 12M | United Arab Emirates, Dubai, United Arab Emirates |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.